Skip to content
OpenCapital
Get started

Edwards Lifesciences EW Japan — Net Sales

Other segment segments

United States
$937.6M+11.8%
Europe
$442.6M+29.5%
Rest of World
$177.8M+18.4%

Similar metrics at other companies

NovoCure logo
NVCRJapan — Net revenues
$10.24M+17.6%
Haemonetics logo
HAEJapan — Net revenues
$18.4M+14.3%
Nature's Sunshine Products logo
NATRJapan — Net Sales
$12.45M+12.9%
Krystal Biotech, Inc. logo
KRYSJapan — Product revenue, net
$8.19M—
Apple logo
AAPLJapan — Net Sales
$8.4B+15.1%
Amkor Technology logo
AMKRJapan — Net Sales
$181.15M-9.5%

Other financials

Income statement

See full
Revenue$1.6B+16.7%
Gross profit$1.3B+15.7%
Operating income$477.6M+21.0%
Net income$380.7M+6.3%
EPS (diluted)$0.66+8.2%

Balance sheet

See full
Cash & equivalents$2.4B-22.3%
Total debt$702.9M+0.5%
Total equity$10.3B+2.0%
Total assets$13.3B+2.3%

Cash flow

See full
Operating cash flow$43.8M-84.4%
CapEx$64.9M+15.9%
Free cash flow-$21.1M-109%

Valuation

See full
Market cap$51.66B+19.3%
Enterprise value$49.92B+22.2%
P/E47.1×+36.8×
P/S8.2×+0.4×

Profitability

See full
Gross margin77.9%-1.6pp
Operating margin21.4%-4.4pp
Net margin17.4%-58.3pp
FCF margin17.3%—

Returns & leverage

See full
Return on equity10.7%-37.8pp
Debt / equity0.1×0.0×
Current ratio4.4×0.0×

Where this comes from

Reported directly by Edwards Lifesciences in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edwards Lifesciences's japan — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Edwards Lifesciences's japan — net sales?
Edwards Lifesciences (EW) reported japan — net sales of $90.6M in Q1 2026.
How has Edwards Lifesciences's japan — net sales changed year-over-year?
Edwards Lifesciences's japan — net sales increased by 10.8% year-over-year, from $81.8M to $90.6M.
What is the long-term trend for Edwards Lifesciences's japan — net sales?
Over 3 years (2021 to 2025), Edwards Lifesciences's japan — net sales has grown at a -12.4% compound annual growth rate (CAGR), from $528M to $354.7M.
What does japan — net sales mean?
This metric represents the total revenue generated from the sale of medical devices and structural heart technologies within the Japanese geographic market. It reflects the company's ability to capture market share and drive adoption of its cardiovascular product portfolio in this specific region. Monitoring this figure helps assess the company's international growth trajectory and regional competitive positioning.